ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Impact of Discards for Living Donor Kidney Transplantation in Center Transplant Program

    H. Villafuerte1, E. De Sousa-Amorim2, L. Peri3, M. Musquera3, E. Palou4, M. Lozano5, J. Cid5, J. Martorell4, J. M. Campistol2, F. Oppenheimer2, F. Diekmann2, I. Revuelta2

    1Department of Nephrology, Hospital Clinic Lozano Blesa, Zaragoza, Spain, 2Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, 3Department of Urology, Hospital Clinic, Barcelona, Spain, 4Department of Immunology, Hospital Clinic, Barcelona, Spain, 5Department of Apheresis, Hospital Clinic, Barcelona, Spain

    *Purpose: New and coming information about the risk of living kidney donors make the effort to study very carefully the option of living kidney donor…
  • 2019 American Transplant Congress

    Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox

    M. Kim1, J. D. Peipert2, K. J. Reid1, E. M. Liotta1, M. B. Maas1, D. R. Ganger3, P. C. Zee1, D. P. Ladner4

    1Neurology, Northwestern University, Chicago, IL, 2Medical Social Sciences, Northwestern University, Chicago, IL, 3Medicine, Northwestern University, Chicago, IL, 4Surgery, Northwestern University, Chicago, IL

    *Purpose: Cognitive impairment (CI) is highly prevalent in liver cirrhosis. Improvement after liver transplant (LT) varies among patients, diminishing the benefits of LT for some.…
  • 2019 American Transplant Congress

    Multimodal Analgesia Reduces Opioid Use after Liver Transplantation

    K. Tong, W. Nolan, D. O'Sullivan, H. Kutzler

    Hartford Hospital, Hartford, CT

    *Purpose: The study aimed to determine if multi-modal pain management (MPM) can reduce opioid use in patients post-liver transplant.*Methods: This was a retrospective review of…
  • 2019 American Transplant Congress

    The Experience of Somatostatin to Prevent Small-for-Size Syndrome in Patients with Small Graft in Living Donor Liver Transplantation

    D. Kim, K. Yoon, H. Jo, W. Kang

    Korea University College of Medicine, Seoul, Korea, Republic of

    *Purpose: The small-for-size syndrome has to be overcome especially in living donor liver transplantation (LDLT) considering the graft and patient survival and morbidities. We introduce…
  • 2019 American Transplant Congress

    Management of Orphan Ducts After Pediatric Living Donor Liver Transplantation

    N. Celik1, A. Ganoza2, A. Khanna2, G. Bond2, K. Soltys2, R. Sindhi2, J. Crowley3, A. Humar1, G. Mazariegos2

    1Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 3Department of Radiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA

    *Purpose: Living donor (LDLT) and split (SLT) livers are two technical variants of standard liver transplants that potentially increase the number of liver allografts available…
  • 2019 American Transplant Congress

    Bespoke Immunosuppression: Prolonging Transplant Survival through Enhanced T-cell Activation Induced Cell Death

    R. Costello1, R. J. Ingram1, D. Longley2, J. McDaid3

    1WWIEM, QUB, Belfast, United Kingdom, 2CCRCB, QUB, Belfast, United Kingdom, 3Renal Transplantation, Belfast City Hospital, Belfast, United Kingdom

    *Purpose: We aim to develop donor-specific immunosuppression by inhibiting T-cell cellular FLICE like inhibitory protein (c-FLIP). Our current work focuses on clinically relevant pharmacological inhibitors…
  • 2019 American Transplant Congress

    Alteration in Local Complement Activation in First 24h Post-Lung Transplantation (LTx) Helps Identify Recipients Developing Primary Graft Dysfunction

    H. Kulkarni1, M. Elvington2, L. Ma1, M. Cano1, K. Pugh3, R. Hachem1, J. Atkinson2, A. Gelman3

    1Pulmonary and Critical Care Medicine, Washington University, Saint Louis, MO, 2Rheumatology, Washington University, Saint Louis, MO, 3Surgery, Washington University, Saint Louis, MO

    *Purpose: Primary graft dysfunction (PGD) is a form of acute lung injury driven by ischemia-reperfusion mediated damage. An increase in plasma complement proteins - specifically…
  • 2019 American Transplant Congress

    The Clinical Outcomes of Kidney Transplant Recipients with Early Graft Failure: A Nationwide Study in South Korea

    Y. Kim1, S. Kwon1, S. Park1, J. Moon1, J. Seon1, J. Kim1, M. Yu2, K. Han3, D. Kim1, Y. Kim1, H. Lee1

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, 2Internal Medicine, Hanyang University Medical Center, Seoul, Korea, Republic of, 3Medical Statistics, Catholic University of Korea, Seoul, Korea, Republic of

    *Purpose: Despite the graft outcome has been steadily improved over the years, early graft failure (EGF) poses a significant threat to kidney transplant (KT) recipients.…
  • 2019 American Transplant Congress

    Beneficial Association between Renin-Angiotensin-Aldosterone-System Blockade Usage and Graft Prognosis in Allograft Immunoglobulin A Nephropathy

    S. Park1, C. Baek2, M. Yu3, Y. Kim1, J. Moon1, H. Go2, Y. Kim2, J. Lee4, S. Min1, J. Ha1, K. Moon1, Y. Kim1, C. Ahn1, S. Park2, H. Lee1

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2Asan Medical Center, Seoul, Korea, Republic of, 3Hanyang University Hospital, Seoul, Korea, Republic of, 4Seoul National University Hospital, Boramae Medical Center, Seoul, Korea, Republic of

    *Purpose: Although immunoglobulin A nephropathy (IgAN) is associated with a high risk of renal allograft failure, evidences for its treatment, including renin-angiotensin-aldosterone system blockade (RAASB)…
  • 2019 American Transplant Congress

    Differential Diagnosis of Membranous Nephropathy Occurs after Bone Marrow Transplantation and Renal Transplantation

    L. Guo1, H. Wang1, Y. Tan2, J. Shen1, R. Wang1, J. Wu1, J. Chen1

    1Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China, 2First Affiliated Hospital of Zhejiang University, Hangzhou, China

    *Purpose: Membranous nephropathy (MN), considered as a rare autoimmune kidney disease, often occurs in synchronization with manifestation of chronic graft-versus-host disease after transplantation. After bone…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences